StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$18.98−0.39 (-2.01%)

Close on Nov 18, 2026Market cap $912.15MP/E –Yield –

Odyssey Therapeutics cash

Cash and short-term investments held at the end of each period.

Odyssey Therapeutics's cash was $310.58M at Jun 30, 2026. For fiscal 2025 it was $181.36M, up 190.9% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$181.36M+190.9%
FY2024Dec 31, 2024$62.35M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$310.58M+465.6%
Q1 FY2026Mar 31, 2026$175.75M+181.9%
Q4 FY2025Dec 31, 2025$181.36M–
Q2 FY2025Jun 30, 2025$163.00M–
Q1 FY2025Mar 31, 2025$54.91M–
Q4 FY2024Dec 31, 2024$62.35M–

More Odyssey Therapeutics figures

See a number that looks wrong?